137 related articles for article (PubMed ID: 3862491)
1. Establishment and characterization of cell lines derived from a human osteosarcoma.
Yamane T
Clin Orthop Relat Res; 1985 Oct; (199):261-71. PubMed ID: 3862491
[TBL] [Abstract][Full Text] [Related]
2. A newly established human osteosarcoma cell line with osteoblastic properties.
Kawai A
Clin Orthop Relat Res; 1990 Oct; (259):256-67. PubMed ID: 2170070
[TBL] [Abstract][Full Text] [Related]
3. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a cell line producing bone morphogenetic protein from a human osteosarcoma.
Takaoka K; Yoshikawa H; Masuhara K; Sugamoto K; Tsuda T; Aoki Y; Ono K; Sakamoto Y
Clin Orthop Relat Res; 1989 Jul; (244):258-64. PubMed ID: 2545399
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions.
Gerstenfeld LC; Uporova T; Schmidt J; Strauss PG; Shih SD; Huang LF; Gundberg C; Mizuno S; Glowacki J
Lab Invest; 1996 May; 74(5):895-906. PubMed ID: 8642785
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of canine osteosarcoma cell lines that induce transplantable tumors in nude mice.
Nieves MA; Vahle J; Ackermann M; Howard M; Dietz AB; Carpenter SL; Cheville N
Am J Vet Res; 1998 Mar; 59(3):359-62. PubMed ID: 9522958
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation.
Kikuchi Y; Takagi M; Parmley RT; Ghanta VK; Hiramoto RN
Cancer Res; 1982 Mar; 42(3):1072-7. PubMed ID: 6174211
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
11. Establishment of transplantable murine osteosarcoma cell line with endochondral ossification.
Nishi T; Kusumi T; Tanaka M; Sato F; Sasaki M; Kudo H; Kijima H
Anticancer Res; 2008; 28(3A):1627-31. PubMed ID: 18630519
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation].
Kikuchi Y; Kizawa I; Kato K
Gan To Kagaku Ryoho; 1982 May; 9(5):888-97. PubMed ID: 6191705
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between the concentration of 1,25 alpha dihydroxyvitamin D3 receptors and growth inhibition, and differentiation of human osteosarcoma cells induced by vitamin D3].
Tokuumi Y
Nihon Seikeigeka Gakkai Zasshi; 1995 Apr; 69(4):181-90. PubMed ID: 7782656
[TBL] [Abstract][Full Text] [Related]
14. Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor.
Izbicka E; Dunstan C; Esparza J; Jacobs C; Sabatini M; Mundy GR
Cancer Res; 1996 Feb; 56(3):633-6. PubMed ID: 8564983
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of cell sublines with high and low metastatic potential derived from human osteosarcoma.
Shi XB; Chen AM; Cai XH; Guo FJ; Liao GN; Ma D
Chin Med J (Engl); 2005 Apr; 118(8):687-90. PubMed ID: 15899125
[No Abstract] [Full Text] [Related]
16. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice.
Berlin O; Samid D; Donthineni-Rao R; Akeson W; Amiel D; Woods VL
Cancer Res; 1993 Oct; 53(20):4890-5. PubMed ID: 8402677
[TBL] [Abstract][Full Text] [Related]
18. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
19. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
[TBL] [Abstract][Full Text] [Related]
20. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.
Ko SC; Cheon J; Kao C; Gotoh A; Shirakawa T; Sikes RA; Karsenty G; Chung LW
Cancer Res; 1996 Oct; 56(20):4614-9. PubMed ID: 8840973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]